Related Experiment Videos
Do peroperative blood transfusions increase the risk of cancer recurrence?
1Virginia Mason Medical Center, Seattle, WA 98101.
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL).
Critical reviews in oncology/hematology·2001
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.
Cancer biotherapy & radiopharmaceuticals·2000
Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results.
Cancer biotherapy & radiopharmaceuticals·2000
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2000
Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2000
Futibatinib after non-covalent FGFR inhibitors in FGFR2-rearranged intrahepatic cholangiocarcinoma: clinical activity and resistance patterns.
European journal of cancer (Oxford, England : 1990)·2026
Thirty years of adjuvant therapy: From treating risk to treating residual disease.
European journal of cancer (Oxford, England : 1990)·2026
Artificial intelligence for brain cancer management: multimodal digital workflows for diagnosis, treatment planning, and longitudinal monitoring.
European journal of cancer (Oxford, England : 1990)·2026
Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma.
European journal of cancer (Oxford, England : 1990)·2026
Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.
European journal of cancer (Oxford, England : 1990)·2026
Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?
European journal of cancer (Oxford, England : 1990)·2026
Partial sequence of L1 gene in HPV 16 and HPV 18 isolated from head-neck squamous cell carcinoma tissues in Bangladesh.
Microbiology resource announcements·2026
Cancer Patients Mortality From Other Causes: A European Population-Based Study.
Cancer medicine·2026
Hemoptysis recurrence after arterial embolization in lung cancer: a 5-year retrospective cohort study.
Diagnostic and interventional radiology (Ankara, Turkey)·2026
Prevalence of Anemia among Patients with Solid Cancer at the Time of Diagnosis in Saudi Arabia.
Clinical laboratory·2026
Genetic Mutations in Patients with Acute Myeloid Leukemia and Their Impact on Prognosis.
Clinical laboratory·2026